Only 12 Pharmaceutical Enterprises in Uzbekistan are GMP-Certified

| By | GMP, Uzbekistan Pharma
0
174

The meeting was held under the chairmanship of the President of the Republic of Uzbekistan Shavkat Mirziyoyev, dedicated to the analysis of the effectiveness of the ongoing work on the development of the pharmaceutical industry and the identification of urgent tasks for the future.

In the field of healthcare in Uzbekistan, about 30 decrees and resolutions have been adopted aimed at expanding the scale and improving the quality of medical services. Work was done to improve the provision of the population and healthcare facilities with affordable medicines and medical devices. In particular, in accordance with the Decree of the President of our country “On measures to radically improve the management system of the pharmaceutical industry” dated November 7, 2017, the Agency for the Development of the Pharmaceutical Industry was created under the Ministry of Health of the Republic of Uzbekistan.

The system work carried out in the field gives its results. In 2017, 1.6 billion conventional packages of medicines and medical devices were produced, which is 34 percent more compared to 2016. Growth in value terms was only 16 percent.

Last year, 71 investment projects were launched in the industry, 33 facilities worth $ 148 million were commissioned, and 76 new products were launched.

At the meeting, the work carried out in the industry was critically analyzed and the unsatisfactory level of fulfillment of the tasks set was noted.

“Most pharmaceutical companies do not use modern technology, and no attention is paid to the production of medicinal substances,”

said Shavkat Mirziyoyev.

Instead of switching to a full production cycle, enterprises are still importing from abroad and packing finished products.

At the meeting it was noted that only 12 out of 94 enterprises have the international GMP certificate (Good Manufacturing Practice), which ensures the recognition of products in other countries. To expand this practice, industry leaders lack initiative. So, deep processing of licorice root for many years remained without due attention. Only after the instruction of the head of state was the Association of licorice production and processing organizations created.

The need for special control on this issue, the importance of moving from the simple collection of wild licorice root to the organization of plantations and the deep processing of this raw material with the production of medicinal substances and agents from it were noted.

They criticized the fact that most of the enterprises in the industry are limited to the production of drugs of a simple formula.

Despite the fact that for several years domestic enterprises have been granted various privileges for the production of import-substituting products, currently, 74 percent of domestic demand is covered by imports.

More than half of the 6824 items of imported drugs can be produced in Uzbekistan, but this figure is currently only 27 percent. Medicines used in oncology, gynecology, dentistry, are fully imported from abroad.

The state of affairs in the supply of state-owned medical institutions with medicines and medical devices remains unsatisfactory. At the meeting, the situation was criticized in which work is progressing slowly, despite the opportunities created by the state, some problems in the industry remain unresolved.

In particular, a system for identifying drug needs and a database containing specific data on this has not been created. Nothing concrete has been done to organize thousands of social pharmacies this year.

Since the adoption of the decree on the creation of 7 free economic zones, more than 9 months have passed, but the corresponding work has not been started in any zone. Their master plans have not been approved, and engineering and communications networks have not been built.

In the pharmaceutical industry, the role of research institutes is not felt. Currently, on the basis of their developments, only 1.6 tons of 16 medicinal substances are produced using plant materials. In addition, the industry lacks personnel capable of working effectively with modern technologies.

The President of Uzbekistan, having deeply analyzed these problems, identified important directions for their elimination. The need was noted for developing a set of additional measures to significantly increase the production of medicinal substances, expand production with a full cycle, and widely introduce international standards and new innovative technologies into the sphere.

The task was set to take additional measures to ensure stability and prevent the artificial increase in drug prices in the domestic market.

Responsible persons were given specific instructions on the development and approval of master plans for free economic zones specializing in pharmaceuticals, providing them with all necessary communications.

The necessity of creating an educational and scientific laboratory and an experimental production complex at the Tashkent Pharmaceutical Institute is pointed out in order to accelerate the implementation of new developments in practice.

The meeting also addressed issues of training personnel in the narrow specialties of pharmaceuticals and organizing internships for industry workers at foreign pharmaceutical enterprises.

SOURCE: regapharm.com
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.